Brazil’s Anvisa updates conduct of clinical trials with Technical Note 22/2020

Anvisa publishes a Technical Note 22/2020 updating the guidelines for sponsors, research centers and investigators involved in conducting clinical trials.
Japan’s MHLW Allows Online IRB Meetings for Coronavirus Trials

Japan’s MHLW issued on April 1, allowing institutional review board (IRB) meetings to be held online or via emails when urgent deliberations are needed to decide whether to approve clinical trials for COVID-19.
FDA publishes guidance on conducting clinical trials during COVID-19 Pandemic.

On March 18, 2020, FDA made widely available a new Guidance Document on managing clinical trials during the COVID-19 pandemic.
FDA Waiving the Informed Consent for Minimal Risk Clinical Studies

On November 2018, FDA proposed a new rule that will allow investigators to request a waiver of the informed consent from the IRB for minimal risk clinical studies.